National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Department of Neurosurgery, China-Japan Friendship Hospital, Chaoyang District, Beijing, China.
J Clin Neurosci. 2022 May;99:22-34. doi: 10.1016/j.jocn.2022.01.020. Epub 2022 Feb 25.
Microvascular decompression (MVD) has been increasingly performed in elderly patients with trigeminal neuralgia (TN). We conducted a meta-analysis to compare the effectiveness and safety of MVD in elderly and young patients with TN.
Databases such as PubMed, EMBASE, and Cochran Library were utilized to collect relevant literatures prior to February 2020. Two researchers independently screened the literature, extracted the data, and evaluated the quality. Finally, the review manager software was used to conduct meta-analysis.
Overall, 12 studies were included in this analysis. The immediate efficacy, long-term efficacy, and complication rate of 681 elderly patients and 1538 young patients were compared after MVD. Results indicated that there were no significant differences in immediate postoperative effects between elderly and younger patients (92.7%: 90.1%, P = 0.13), while the postoperative long-term efficacy of elderly patients were significantly better than young patients (77.5%: 71.2 %, P = 0.04). There were no significant differences in the incidence of intracranial hemorrhage, bacterial meningitis, cerebrospinal fluid leakage, facial hypoesthesia, hearing impairment, and facial paralysis between the two age groups.
MVD is an effective and safe treatment in the elderly patient population. Older patients tend to achieve better long-term results and advanced age should not be a contraindication for MVD treating TN.
微血管减压术(MVD)已越来越多地应用于老年三叉神经痛(TN)患者。我们进行了一项荟萃分析,比较了 MVD 治疗老年和年轻 TN 患者的疗效和安全性。
我们检索了 PubMed、EMBASE 和 Cochrane 图书馆等数据库,收集了截至 2020 年 2 月的相关文献。两位研究人员独立筛选文献、提取数据并评估质量。最后使用 Review Manager 软件进行荟萃分析。
共有 12 项研究纳入本分析。比较了 MVD 后 681 例老年患者和 1538 例年轻患者的即刻疗效、长期疗效和并发症发生率。结果表明,老年患者和年轻患者术后即刻效果无显著差异(92.7%:90.1%,P=0.13),但老年患者术后长期疗效明显优于年轻患者(77.5%:71.2%,P=0.04)。两组患者颅内出血、细菌性脑膜炎、脑脊液漏、面部感觉减退、听力障碍和面瘫的发生率无显著差异。
MVD 治疗老年三叉神经痛患者是有效且安全的。老年患者往往能获得更好的长期疗效,年龄增长不应成为 MVD 治疗 TN 的禁忌证。